Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.
Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hernández M, Gea A, Arruti E, Aldecoa C, Martínez-Pallí G, Martínez-González MA, Slutsky AS, Villar J; COVID-19 Spanish ICU Network. Ferrando C, et al. Intensive Care Med. 2020 Dec;46(12):2200-2211. doi: 10.1007/s00134-020-06192-2. Epub 2020 Jul 29. Intensive Care Med. 2020. PMID: 32728965 Free PMC article.
Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain.
Álvarez-Gallego R, Pazo-Cid R, López de San Vicente B, Macarulla T, Martinez E, Garicano F, Hernández I, Granja M, Ghanem I, Martinez J, Ribera P, Diaz R, Martin Valadés JI, Angeles MC, Cubillo A. Álvarez-Gallego R, et al. Among authors: hernandez i. Ther Adv Med Oncol. 2025 Jan 8;17:17588359241309828. doi: 10.1177/17588359241309828. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 39781240 Free PMC article.
CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds.
Amarilla-Quintana S, Navarro P, Hernández I, Ramos A, Montero-Calle A, Cabezas-Sainz P, Barrero MJ, Megías D, Vilaplana-Martí B, Epifano C, Gómez-Dominguez D, Monzón S, Cuesta I, Sánchez L, Barderas R, García-Donas J, Martín A, Pérez de Castro I. Amarilla-Quintana S, et al. Among authors: hernandez i. Mol Oncol. 2025 Jan 8. doi: 10.1002/1878-0261.13799. Online ahead of print. Mol Oncol. 2025. PMID: 39776254 Free article.
1,142 results